logo transparent gif
top_white_spacer
Home Latest Forum Topics MyCorner - Personal Stocks Porfolio Stock Lists Forex Investor Insights Investment News Investor Research & Links Dynamic Stock Charting FREE Registration About Us top spacer top spacer
 User Password Auto-Login
Enter Stock
 
righttip
branding

Return

IX Biopharma

42C

0.021

-0.001

GroupCash
CashSingapore Dollar
18-Feb 12:58

 

TRADING INFO

Open
0.021
Buy
0.021
Sell
0.022
High
0.021
Low
0.021
Previous Close
0.022
Volume(K)
432.9
Buy Volume(K)
559.0
Sell Volume(K)
266.2

KEY STOCK INFOUpdated: 05 Dec 2024

PE Ratio (FY)
NA
Dividend Yield % (FY)
-
Price to Book Ratio
-
Market Cap ($million)
-
Enterprise Value ($million)
-
52 Weeks High
0.05635761
52 Weeks Low
0.021
RSI
45.05 ( No Info )
Williams %R
-66.67 ( No Info )

 

COMPANY INFORMATION Updated: 15 Feb 2025 Financial Info by

SIC
IN VITRO AND IN VIVO DIAGNOSTIC SUBSTANCES
Address
20 COLLYER QUAY, #11-07 SINGAPORE 049319
Phone
(65) 6235 2170
Fax
(65) 8928 8467
Profile
The principal activities of the Company are the development, manufacture and commercialisation of innovative therapies for the treatment of acute and breakthrough pain, and male erectile dysfunction.
AUDITOR
PRICEWATERHOUSECOOPERS LLP

 

FINANICALS INFORMATION All values in $millions

Financial Year
2023-06-30
2024-06-30
2023-06-30
Currency
SGD
SGD
SGD
KEY RATIOS
FY 2022
FY 2023
FY 2023
Operating Margin(%)
-159.564
-160.144
-159.564
Return on Equity Capital(%)
-54.023
-106.914
-54.023
Net Profit Margin(%)
-162.608
-181.138
-162.608
Current Ratio
1.53
0.892
1.53
Debt to Capital at Book
0.174
0.356
0.174
INCOME STATEMENT
FY 2022
FY 2023
FY 2023
EBITDA
-7.482
-6.005
-7.482
EBIT
-8.411
-7.034
-6.669
Net Profit
-9.615
-10.794
-9.615
Ordinary Dividend
0.0
0.0
0.0
BALANCE SHEET
FY 2022
FY 2023
FY 2023
Intangibles
1.47
0.295
0.291
Fixed Assets
7.23
7.12
7.23
Long Term Investments
0.0
0.126
0.189
Stock/Inventories
0.956
1.38
0.956
Cash
6.519
1.771
6.519
Current Liabilities
7.175
7.381
7.175
Long Term Debt
0.568
0.403
0.568
Provisions
0.039
0.04
0.039
Minorities
0.0
0.0
0.0
Total Shareholder Equity
15.852
4.34
15.852
PER SHARE INFO
FY 2022
FY 2023
FY 2023
EBITDA per share
-0.01
-0.008
-0.01
EBIT per share
-0.013
-0.013
-0.013
Profit Per Share
-0.013
-0.014
-0.013
Book Value Per Share
0.019
0.005
0.02

 

 


Intraday Chart
S68 chart by TradingView

ShareJunction Version: 27 Nov 2020 ver- All Rights Reserved. Copyright ShareJunction Pte. Ltd. Disclaimer: All prices from are delayed. ShareJunction does not provide you with any financial advice. We are not into the business of providing any investment advice. See our Terms and Conditions and Privacy Policy of using this website. Data is delayed for varying periods of time depending on the exchange, but for at least 15 minutes. Copyright © SIX Financial Information Ltd. and its licensors. All Rights reserved. Further distribution and use by third parties prohibited. SIX Financial Information and its licensors make no warranty for information displayed and accept no liability for data and prices. SIX Financial Information reserves the right to adapt and/or alter this website at any time without prior notice.

Web design by FoundationFlux.